News Hub | News Direct

All Industries


Article thumbnail News Release

Beal University’s Health Information Management Program Receives Initial Accreditation for Seven Years

Beal University

Beal University is proud to announce that its Health Information Management (HIM) Baccalaureate Degree Program has been awarded Initial Accreditation for Seven Years by the Commission on Accreditation for Health Informatics and Information Management Education (CAHIIM). The accreditation was granted following a comprehensive program review conducted by the Health Information Management Accreditation Council and the CAHIIM Board of Directors. The vote to award initial accreditation to Beal University’s HIM program took place on February 16, 2024. This accreditation underscores the program’s substantial compliance with the nationally established CAHIIM 2018 Health Information Management Accreditation Standards. Beal University’s HIM program has demonstrated a commitment to continuous quality improvement in higher education, as recognized by CAHIIM. “We are thrilled to receive initial accreditation for our Health Information Management Baccalaureate Degree Program,” said Sheryl DeWalt, MBA, CPA, President of Beal University. “This accreditation is a testament to the dedication and hard work of our faculty, staff, and students in upholding the highest standards of education in health informatics and information management.” The HIM program at Beal University equips students with the knowledge and skills necessary to succeed in the rapidly evolving field of health information management. Through a comprehensive curriculum and hands-on learning experiences, students gain expertise in managing health information systems, ensuring data accuracy and security, and utilizing technology to improve healthcare delivery. The CAHIIM accreditation serves as a mark of quality and excellence in health informatics and information management education. It signifies that Beal University’s HIM program meets or exceeds the rigorous standards set forth by CAHIIM, ensuring that graduates are well-prepared to excel in their careers as health information management professionals. Beal University is committed to delivering a high-quality education and real-world experiential opportunities that positions its graduates for success. Beal’s instructors have working experience in the health information industry and our curriculum aligns with the current environment. This accelerated but flexible online baccalaureate program can be completed in 38 months (about 3 years) for new students but is designed as a seamless stepladder approach that empowers our existing health information technology associate degree graduates to earn a bachelor’s degree with only 18 additional months. Beal University’s bachelor’s in HIM offers graduates a chance to improve advancement opportunities and earn one or more highly sought after credentials. The health information management Bachelor of Science program prepares students for various career pathways in health information and informatics, revenue cycle management, data quality and analytics, health information privacy, risk management, and health care compliance. With initial accreditation secured, Beal University’s HIM program will undergo a comprehensive program review for continuing accreditation in 2031-2032. The university looks forward to continuing its tradition of excellence in health informatics and information management education. For more information about Beal University’s Health Information Management Baccalaureate Degree Program, visit Beal University Health Information Management Program Contact Details Beal University Beal University Admissions +1 800-660-7351 admissions@bealuniversity.ca

March 19, 2024 02:48 PM Eastern Daylight Time

Article thumbnail News Release

Shaping the Future of Healthcare: Benzinga Virtual Healthcare Summit 2024

Benzinga

Benzinga is thrilled to present the 2024 Virtual Healthcare Summit, a groundbreaking virtual event poised to revolutionize the landscape of healthcare. This summit is a beacon of innovation, bringing together leading companies, healthcare visionaries, analysts, asset managers, and thought leaders to shape the future of health. Scheduled for Wednesday, March 20, starting at 10:25 AM EST, this summit is set to attract tens of thousands of attendees eager to explore the latest advancements and insights driving the healthcare industry forward. Our esteemed sponsors for the event include: The Beachbody Company Cardio Diagnostics Holdings, Inc. Elicio Therapeutics Theriva Biologics, Inc. First Wave BioPharma Plus Therapeutics BioHarvest Sciences ZyVersa Therapeutics IN8Bio, Inc. IGC Pharma Atossa Therapeutics Autonomix Medical, Inc. AXIM Biotechnologies ImmunoPrecise Antibodies Ltd. The agenda for the summit features an impressive lineup of speakers, including: Don Duffy, President at ICR John Huemoeller, CEO at AXIM Biotechnologies Steve A. Shallcross, CEO at Theriva Biologics Manel Cascallo, General Director, EU Subsidiary at Theriva Biologics Laura Chico, PhD, Senior Vice President, Equity Research Freda Lewis-Hall; Michael O'Brian, Partner & Head of US Healthcare PR at ICR & Westwicke David Song, Investment Partner and Head of Life Sciences at TEMA ETFs Lori Bisson, CEO at Autonomix Medical Steven Qua, MD, PhD, President & CEO at Atossa Therapeutics Ilan Sobel, CEO at BioHarvest Sciences Ram Mukunda, CEO at IGC Pharmaceuticals Claudia Grimaldi, VP, CCO, PFO, & Director at IGC Pharmaceuticals Mark Klausner, Managing Director, Head of U.S. Healthcare Investor Relations at ICR Westwicke Adam Mendelsohn, PH.D., Co-Founder & CEO at Vivani Medical Meesha Dogan, CEO, Co-founder & Director at Cardio Diagnostics Steve Glover, Co-founder, Chairman, CEO, & President at ZyVersa Therapeutics Robert Jacks, President & CEO at Sparrow Pharmaceuticals Marc Hedrick, President & CEO at Plus Therapeutics William Ho, CEO at IN8Bio, Inc Mark Goldston, Executive Chairman at The Beachbody Company Dr. Jennifer Bath, CEO at Immunoprecise Antibodies Ltd. Robert Connelly, CEO at Elicio Therapeutics Sameer Khambadkone, Managing Director at ICR/Westwicke Each speaker brings invaluable expertise and perspectives, promising enriching discussions that will shape the future of healthcare. Join us as we embark on this transformative journey in healthcare. Registration is now open, and participation is free. Don't miss the opportunity to be part of this historic event and contribute to shaping the future of health. For more information and to register, visit the event registration page. Drew Pilat Benzinga 1 Campus Martius, Detroit, MI 48226 drew@benzinga.com benzinga.com/events Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. Contact Details Benzinga +1 877-440-9464 drew@benzinga.com Company Website http://www.benzinga.com

March 19, 2024 02:00 PM Eastern Daylight Time

Article thumbnail News Release

Galileo Mining identifies drill targets ahead of drill season at Norseman

GALILEO MINING LTD

As it moves a step closer to a new drilling season, Galileo Mining Ltd (ASX:GAL) managing director Brad Underwood sits down with Jonathan Jackson to discuss the program and identified targets. The targets, identified through modelling of induced polarisation (IP) survey data, revealed strong chargeable anomalies near the notable Callisto nickel-palladium deposit. With drilling planned to start in late April, Galileo will test these anomalies for economic mineralisation, focusing on disseminated sulphide deposits similar to those found at Callisto. Underwood emphasised the strategic use of IP surveying and geological mapping in pinpointing these promising targets, reflecting the same rock sequence hosting the Callisto deposit. “Our first drill targets for the 2024 drilling season have been confirmed with strong geophysical anomalies close to known mineralisation," Underwood said. "These drill targets are significant as they are based on IP surveying, which is specifically designed to look for disseminated sulphide, and on geological mapping which confirms the existence of the same rock sequence which hosts the Callisto deposit. "The breakthrough discovery of the PGE-nickel Callisto deposit in 2022 has convincingly increased the probability of new discoveries within our highly prospective 255 square kilometre Norseman land position." Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 01:00 PM Eastern Daylight Time

Video
Article thumbnail News Release

Elixir Energy advances gas projects in Queensland and Mongolia

ELIXIR ENERGY LIMITED

Elixir Energy Ltd (ASX:EXR) managing director Neil Young sits down with Proactive’s Jonathan Jackson to discuss the significant strides the company is making in de-risking its gas projects in Queensland and Mongolia. Its Daydream-2 well at the Grandis Project in Queensland is set to undergo rigorous stimulation and flow testing activities, managed by Halliburton, through mid-year. This activity in the Taroom Trough is generating increasing interest in the gas sector. In parallel, Elixir continues to progress its Nomgon Pilot Project in Mongolia. The focus remains on depressurising the gas-bearing coal reservoir, a crucial step achieved through the continuous extraction of water. This dual-front approach underlines Elixir Energy's commitment to meeting its core de-risking objectives for both projects. Young said: “We are pleased that operations at both of our large gas projects in Queensland and Mongolia are on track to meet their core de-risking objectives. "The Daydream-2 well at Grandis will be the scene of intense activity through to around the middle of the year as we now move into the key stimulation and flow testing phases. "Given this, we are very pleased to note that the current activities by a range of Operators in the Taroom Trough is drawing more and more gas industry attention.” Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 01:00 PM Eastern Daylight Time

Video
Article thumbnail News Release

OzAurum to start drilling at Boca Rica Lithium Project

OZAURUM RESOURCES LIMITED

OzAurum Resources Ltd (ASX:OZM) CEO and managing director Andrew Pumphrey sits down with Proactive’s Jonathan Jackson to discuss an upcoming drilling program at Boca Rica Lithium Project in Brazil, following the identification of a spodumene zone. The company plans to start drilling in the next three to four weeks, contingent on weather and the receipt of environmental permits. Pumphrey emphasised the project's potential for a major lithium discovery, highlighting the strategic scale of the site and the comprehensive fieldwork conducted in Brazil. Besides Boca Rica, OzAurum is actively pursuing other lithium opportunities and is engaged in discussions for additional acquisitions. The company also has interest in niobium and rare earth element (REE) opportunities in Brazil, and has lodged applications for 50,000 hectares of tenure prospective for niobium and REE near known Brazilian carbonatite complexes. Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 12:35 PM Eastern Daylight Time

Video
Article thumbnail News Release

Celsius Resources granted major permit; paves way for copper development

CELSIUS RESOURCES LIMITED

In what is perhaps the company’s biggest milestone to date, Celsius Resources Ltd (ASX:CLA) managing director Peter Hume sits down with Proactive’s Jonathan Jackson to discuss the importance of its Philippine subsidiary, Makilala Mining Company, Inc. (MMCI), being granted a Mineral Production Sharing Agreement (MPSA) for the Maalinao-Caigutan-Biyog Mining Project (MCB). Issued by the Philippine Department of Environment and Natural Resources on March 14, 2024, this permit is valid for 25 years and renewable for another 25 and represents a pivotal step for Celsius in transitioning from an exploration entity to a mineral resource developer and future mine operator. The MPSA, the first copper project approval in the Philippines in the last 15 years, endows MMCI with exclusive rights for the exploration, development, and production of copper and associated minerals within the 2,500-hectare contract area. This development catalyses the MCB project's progression towards operational status. Hume lauded the achievement as a testament to the diligence of the in-country team and a critical juncture in the company’s evolution. Granting of the permit is expected to stimulate financial investments, with Celsius already engaging with potential backers. With the permit secured, Celsius is set to finalise funding mechanisms, advancing the MCB project into its next developmental phase. Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 11:15 AM Eastern Daylight Time

Video
Article thumbnail News Release

Alkane Resources nears Kaiser resource upgrade with record gold hits

Alkane Resources Limited

On the brink of significantly upgrading the mineral resource estimate for its Kaiser deposit in the Northern Molong Porphyry Project in New South Wales, Alkane Resources Ltd (ASX:ALK) managing director Nic Earner takes Proactive’s Jonathan Jackson through the latest drilling results. Alkane has delivered the highest gold grades observed to date at the site, with an exceptional intercept of 8.6 metres at 14.8 g/t gold equivalent, including segments of 3.5 metres at 31.3 g/t and 1 metre at 62.2 g/t gold equivalent. Earner highlights the remarkable findings from the final 12,000-metre round of drilling, which confirmed the presence of high-grade sections and a 'Boda' style breccia, intensifying the deposit’s prospects. With these results, Alkane is poised to release an updated Kaiser resource estimate in April, enhancing the already impressive Boda resource figures. Looking forward, the company is conducting a scoping study to assess the mining viability of both Boda and Kaiser, with results expected in the June quarter. Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 11:15 AM Eastern Daylight Time

Video
Article thumbnail News Release

Ionic Rare Earths on track to be first ASX producer of rare earth oxides from recycled wind turbines

IONIC RARE EARTHS LIMITED

Ionic Rare Earths Ltd (ASX:IXR) managing director Tim Harrison joins Jonathan Jackson in the Proactive studio as the company sets itself to become the first ASX-listed company to produce magnet rare earth oxides (REOs) from recycled wind turbines. Harrison highlights the company's journey towards becoming a major producer of recycled separated magnet REO, a milestone that positions IonicRE as a frontrunner in establishing a sustainable supply chain outside China. IonicRE's innovative approach targets the recycling of permanent magnets from decommissioned wind turbines, a market that is rapidly expanding, particularly in Europe. The company's Belfast Demonstration Plant is making significant strides in magnet REO production, with a focus on the processing of NdPr/DyHo separation following the successful creation of mixed REO products. In 2023, the European wind energy sector saw the decommissioning of 736 MW of power across nine countries, indicating a substantial opportunity for IonicRE's recycling initiative. With more than 3,000 wind turbines in Ireland alone, IonicRE is at the forefront of delivering a secure, clean and green supply chain, crucial for the wind farm industry and broader renewable energy sectors in achieving global decarbonisation goals. The company's executive chairman Brett Lynch said: “This is a major step forward in the development of an ex-China supply chain, with IonicRE offering the potential to become the first and only REO recycler from wind turbine magnets in the Western world. “The size of the prize is significant, given the tremendous rate of growth in the wind turbine market, particularly given our proximity to the UK and Northern Ireland wind farms market with the Port of Belfast on our doorstep. "With over 3,000 wind turbines located across the island of Ireland, the opportunity is compelling." Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 11:00 AM Eastern Daylight Time

Video
Article thumbnail News Release

Kuehn Law Encourages FUSN, KAMN, DRQ, and VZIO Investors to Contact Law Firm

Kuehn Law

Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) click to participate Fusion Pharmaceuticals has agreed to be acquired by AstraZeneca. Under the agreement, shareholders of Fusion will be entitled to a payment of $21.00 per share in cash plus a non-transferable CVR of $3.00. Kaman Corp. (NYSE: KAMN) click to participate Kaman has reached a deal to be quired by Arcline Investment Management, L.P. In this deal, each Kaman shareholder will be paid $46.00 per share in a cash transaction. Dril-Quip, Inc. (NYSE: DRQ) click to participate Dril-Quip has agreed to merge with Innovex Downhole Solutions. Under the agreement, shareholders of Dril-Quip will own approximately 52% of the combined company. VIZIO Holding Corp. (NYSE: VZIO) click to participate VIZIO has agreed to be acquired by Walmart. Under the agreement, shareholders of VIZIO will be entitled to $11.50 per share in cash. Why Your Participation Matters: As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future. ™ How to Get Involved: Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Details Kuehn Law, PLLC Justin Kuehn, Esq +1 833-672-0814 justin@kuehn.law Company Website https://www.kuehn.law/

March 19, 2024 10:55 AM Eastern Daylight Time

1 ... 331332333334335 ... 3755